Поисковый запрос: (<.>S=ЭНТЕКАВИР<.>) |
Общее количество найденных документов : 95
Показаны документы с 1 по 20
|
|
1.
| Ren A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B // World J. Gastroenterol., 2007. Vol. 13, N 31.-С.4264-4267
|
2.
| Ren A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B // World J. Gastroenterol., 2007. Vol. 13, N 31.-С.4264-4267
|
3.
| Anti-HBs seroconversion during treatment with entecavir in a patient with chronic hepatitis B virus infection on hemodialysis // J. Med. Virol., 2014. Vol. 86, N 1.-С.139-143
|
4.
| Antiviral efficacy of combination therapy with entecavir and adefocir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance // J. Med. Virol., 2012. Vol. 84, N 3.-С.424-430
|
5.
| Antiviral efficacy of combination therapy with entecavir and adefocir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance // J. Med. Virol., 2012. Vol. 84, N 3.-С.424-430
|
6.
| Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine // Antimicrob. Agents and Chemother., 2004. Vol. 48, N 9.-С.3498-3507
|
7.
| Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine // Antimicrob. Agents and Chemother., 2004. Vol. 48, N 9.-С.3498-3507
|
8.
| Wang J.C. Comparison of re-treatment outcomes of lamivudine plus adefovir or entecavir in chronic hepatitis B patients with viral relapse after cessation of adefovir // Eur. Rev. Med. and Pharmacol. Sci., 2013. Vol. 17, N 9.-С.1162-1166
|
9.
| Wang J.C. Comparison of re-treatment outcomes of lamivudine plus adefovir or entecavir in chronic hepatitis B patients with viral relapse after cessation of adefovir // Eur. Rev. Med. and Pharmacol. Sci., 2013. Vol. 17, N 9.-С.1162-1166
|
10.
| Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments // J. Med. Virol., 2015. Vol. 87, N 6.-С.999-1007
|
11.
| Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis B // J. Med. Virol., 2011. Vol. 83, N 7.-С.1178-1186
|
12.
| Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis B // J. Med. Virol., 2011. Vol. 83, N 7.-С.1178-1186
|
13.
| Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis B // J. Med. Virol., 2011. Vol. 83, N 7.-С.1178-1186
|
14.
| Early entecavir treatment for chronic hepatitis B with severe acute exacerbation // Antimicrob. Agents and Chemother., 2014. Vol. 58, N 4.-С.1918-1921
|
15.
| Efficacy of entecavir and adefovir combination therapy for patients with lamivudine - and entecavir-resistant chronic hepatitis B // Dig. Diseases and Sci., 2012. Vol. 57, N 5.-С.1358-1365
|
16.
| Efficacy of entecavir and adefovir combination therapy for patients with lamivudine - and entecavir-resistant chronic hepatitis B // Dig. Diseases and Sci., 2012. Vol. 57, N 5.-С.1358-1365
|
17.
| Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma // Brit. J. Haematol., 2008. Vol. 143, N 1.-С.148-150
|
18.
| Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma // Brit. J. Haematol., 2008. Vol. 143, N 1.-С.148-150
|
19.
| Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma // Brit. J. Haematol., 2008. Vol. 143, N 1.-С.148-150
|
20.
| Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 2.-С.598-605
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"